Revivicor, Inc.

Biotechnology ResearchVirginia, United States11-50 Employees

Revivicor, Inc. operates in the biotechnology research space, focusing on innovations that involve pigs and human genes with the aim of addressing medical needs. Based in Blacksburg, Virginia, the company has a moderate size and concentrates on developing technologies and products relevant to therapeutic development and immune-related applications. Recent activity highlights the company’s work in modifying pigs to express human traits, such as incorporating human genes to reduce complications like blood clotting and inflammation, which illustrates its broader interest in advancing biologically engineered solutions for human health. The organization is part of a broader biotech ecosystem that includes other firms pursuing specialized biologics and antibody technologies.

Historically, Revivicor has been associated with large-scale partnerships and corporate activity within the biotechnology landscape, including its relationship with United Therapeutics Corp. The company operates within the biotechnology research industry, with a focus on translating genetic and cellular approaches into clinically relevant platforms. Its location in Blacksburg situates it within a regional hub for scientific research, while its scope appears oriented toward collaboration with larger entities and potential applications in medical science that rely on genetically modified animal models.

Sign up for free to view info

Email Format Employee directory